Clinical Trial Update: Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating urokinase for diabetic foot syndrome and critical limb ischemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot

Drugs mentioned

• Urokinase (urokinase)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Diabetic Foot, Critical Limb Ischemia | Phase 3 | Status: TERMINATED